
TheraLyze.ai is a technology company specializing in AI-driven automation for pharmacovigilance case intake. Their platform eliminates manual data entry by using advanced AI and natural language processing to extract key safety data from unstructured documents and generate structured E2B R3 files compliant with regulatory standards. The solution integrates seamlessly with any pharmacovigilance database, enhancing speed, accuracy, and compliance while reducing operational costs. TheraLyze.ai serves pharmaceutical companies and CROs, demonstrated by successful deployments such as with Wörwag Pharma, which achieved significant reductions in case processing time and improved regulatory submission efficiency. The company operates on a SaaS model, providing scalable, GDPR and HIPAA compliant solutions that streamline workflows and improve data quality in drug safety operations.

TheraLyze.ai is a technology company specializing in AI-driven automation for pharmacovigilance case intake. Their platform eliminates manual data entry by using advanced AI and natural language processing to extract key safety data from unstructured documents and generate structured E2B R3 files compliant with regulatory standards. The solution integrates seamlessly with any pharmacovigilance database, enhancing speed, accuracy, and compliance while reducing operational costs. TheraLyze.ai serves pharmaceutical companies and CROs, demonstrated by successful deployments such as with Wörwag Pharma, which achieved significant reductions in case processing time and improved regulatory submission efficiency. The company operates on a SaaS model, providing scalable, GDPR and HIPAA compliant solutions that streamline workflows and improve data quality in drug safety operations.